Trending stocks today
Revance Therapeutics (RVNC-Q)
NASDAQ:RVNC
3.80
0.07
(1.74%) 1d
Financials
Technical Analysis
N/A
Unknown
Abbvie as competition Abbvie's CEO hasn't turned the juice on Allergan (a company ABBV bought last year) and he's very competitive. When he turns it on, it will hurt EVNC. Be careful with RVNC. He wishes he liked Revance more. He knows this group (aesthetics) and Abbvie produces the popular Botox.
- «
- ‹
- 1
- ›
- »
Revance Therapeutics(RVNC-Q) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Revance Therapeutics(RVNC-Q) Frequently Asked Questions
What is Revance Therapeutics stock symbol?
Revance Therapeutics is a American stock, trading under the symbol RVNC-Q on the NASDAQ (RVNC). It is usually referred to as NASDAQ:RVNC or RVNC-Q
Is Revance Therapeutics a buy or a sell?
In the last year, there was no coverage of Revance Therapeutics published on Stockchase.
Is Revance Therapeutics a good investment or a top pick?
Revance Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Revance Therapeutics.
Why is Revance Therapeutics stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Revance Therapeutics worth watching?
In the last year, there was no coverage of Revance Therapeutics published on Stockchase.
What is Revance Therapeutics stock price?
On 2024-12-03, Revance Therapeutics (RVNC-Q) stock closed at a price of $3.795.
There's demand for products to improve skin care and appearance, because people want to look good.